Literature DB >> 11790788

Corticotropin-releasing hormone induces Fas ligand production and apoptosis in PC12 cells via activation of p38 mitogen-activated protein kinase.

Erini Dermitzaki1, Christos Tsatsanis, Achille Gravanis, Andrew N Margioris.   

Abstract

Recent experimental findings involve corticotropin-releasing hormone (CRH) in the cellular response to noxious stimuli and possibly apoptosis. The aim of the present work was to examine the effect of CRH on apoptosis and the Fas/Fas ligand system in an in vitro model, the PC12 rat pheochromocytoma cell line, which is widely used in the study of apoptosis and at the same time expresses the CRH/CRH receptor system. We have found the following. CRH induced Fas ligand production and apoptosis. These effects were mediated by the CRH type 1 receptor because its antagonist antalarmin blocked CRH-induced apoptosis and Fas ligand expression. CRH activated p38 mitogen-activated protein kinase, which was found to be essential for CRH-induced apoptosis and Fas ligand production. CRH also promoted a rapid and transient activation of ERK1/2, which, however, was not necessary for either CRH-induced apoptosis or Fas ligand production. Thus, CRH promotes PC12 apoptosis via the CRH type 1 receptor, which induces Fas ligand production via activation of p38.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11790788     DOI: 10.1074/jbc.M111236200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

Review 1.  Insights into mechanisms of corticotropin-releasing hormone receptor signal transduction.

Authors:  Dimitris K Grammatopoulos
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Sex- and corticotropin-releasing factor receptor 2- dependent actions of urocortin 1 during inflammation.

Authors:  Burcu Hasdemir; Pallavi Mhaske; Sreenivasan Paruthiyil; Elizabeth A Garnett; Melvin B Heyman; Mehrdad Matloubian; Aditi Bhargava
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-04-06       Impact factor: 3.619

3.  Corticotropin releasing factor-1 receptor antagonism alters the biochemical, but not behavioral effects of repeated interleukin-1β administration.

Authors:  Clare J Wilhelm; Aaron Murphy-Crews; Daniel J Menasco; Marilyn S Huckans; Jennifer M Loftis
Journal:  Neuropharmacology       Date:  2011-08-04       Impact factor: 5.250

4.  Inhibiting interleukin-18 production through the mitogen-activated protein kinase pathway, a potential role of corticotropin-releasing hormone in chronic plaque psoriasis.

Authors:  Chun-Lei Zhou; Xiao-Jing Yu; Da-Xing Cai; Yong-Hao Xu; Chun-Yang Li; Qing Sun
Journal:  Inflammation       Date:  2015       Impact factor: 4.092

Review 5.  HPA axis responsiveness to stress: implications for healthy aging.

Authors:  Greti Aguilera
Journal:  Exp Gerontol       Date:  2010-09-09       Impact factor: 4.032

6.  Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice.

Authors:  Sofia Agelaki; Christos Tsatsanis; Achille Gravanis; Andrew N Margioris
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

7.  CRH inhibits NF-kappa B signaling in human melanocytes.

Authors:  Blazej Zbytek; Lawrence M Pfeffer; Andrzej T Slominski
Journal:  Peptides       Date:  2006-09-07       Impact factor: 3.750

8.  Activation of phosphatidylinositol 3-kinase/protein kinase B by corticotropin-releasing factor in human monocytes.

Authors:  Christina Chandras; Yassemi Koutmani; Efi Kokkotou; Charalabos Pothoulakis; Katia P Karalis
Journal:  Endocrinology       Date:  2009-07-23       Impact factor: 4.736

9.  Urocortin induced expression of COX-2 and ICAM-1 via corticotrophin-releasing factor type 2 receptor in rat aortic endothelial cells.

Authors:  Rongjian Zhang; Youhua Xu; Hong Fu; Juejin Wang; Lai Jin; Shengnan Li
Journal:  Br J Pharmacol       Date:  2009-08-19       Impact factor: 8.739

10.  Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins.

Authors:  Ioannis Charalampopoulos; Christos Tsatsanis; Erene Dermitzaki; Vasilia-Ismini Alexaki; Elias Castanas; Andrew N Margioris; Achille Gravanis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.